These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35656937)

  • 41. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
    Doppalapudi S; Jain A; Chopra DK; Khan W
    Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ethosomes Loaded with Cryptotanshinone for Acne Treatment through Topical Gel Formulation.
    Yu Z; Lv H; Han G; Ma K
    PLoS One; 2016; 11(7):e0159967. PubMed ID: 27441661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
    Shinde UA; Parmar SJ; Easwaran S
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TPGS assists the percutaneous administration of curcumin and glycyrrhetinic acid coloaded functionalized ethosomes for the synergistic treatment of psoriasis.
    Guo T; Lu J; Fan Y; Zhang Y; Yin S; Sha X; Feng N
    Int J Pharm; 2021 Jul; 604():120762. PubMed ID: 34082000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: Superiority of amino modification.
    Li J; Xu L; Wang H; Yang B; Liu H; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():710-716. PubMed ID: 26652425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanoemulgel for Improved Topical Delivery of Desonide: Formulation Design and Characterization.
    Ma Q; Zhang J; Lu B; Lin H; Sarkar R; Wu T; Li X
    AAPS PharmSciTech; 2021 May; 22(5):163. PubMed ID: 34031790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration.
    Rattanapak T; Young K; Rades T; Hook S
    J Pharm Pharmacol; 2012 Nov; 64(11):1560-9. PubMed ID: 23058043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Indomethacin-loaded methoxy poly(ethylene glycol)/ poly(epsilon-caprolactone) diblock copolymeric nanosphere: pharmacokinetic characteristics of indomethacin in the normal Sprague-Dawley rats.
    Kim SY; Lee YM; Shin HJ; Kang JS
    Biomaterials; 2001 Jul; 22(14):2049-56. PubMed ID: 11426885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ethosomes for enhanced skin delivery of griseofulvin.
    Marto J; Vitor C; Guerreiro A; Severino C; Eleutério C; Ascenso A; Simões S
    Colloids Surf B Biointerfaces; 2016 Oct; 146():616-23. PubMed ID: 27429295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Fluorouracil ethosomes - skin deposition and melanoma permeation synergism with microwave.
    Khan NR; Wong TW
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):568-577. PubMed ID: 29378453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers.
    Rao Y; Zheng F; Zhang X; Gao J; Liang W
    AAPS PharmSciTech; 2008; 9(3):860-5. PubMed ID: 18649143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
    Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
    Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis.
    Zhang YT; Shen LN; Zhao JH; Feng NP
    Int J Nanomedicine; 2014; 9():669-78. PubMed ID: 24489470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
    Zhang YT; Shen LN; Wu ZH; Zhao JH; Feng NP
    Int J Pharm; 2014 Aug; 471(1-2):449-52. PubMed ID: 24907596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
    Paolino D; Lucania G; Mardente D; Alhaique F; Fresta M
    J Control Release; 2005 Aug; 106(1-2):99-110. PubMed ID: 15935505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent Developments in the Principles, Modification and Application Prospects of Functionalized Ethosomes for Topical Delivery.
    Lu J; Guo T; Fan Y; Li Z; He Z; Yin S; Feng N
    Curr Drug Deliv; 2021; 18(5):570-582. PubMed ID: 32851961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topical delivery of enoxaparin using nanostructured lipid carrier.
    Jain A; Mehra NK; Nahar M; Jain NK
    J Microencapsul; 2013; 30(7):709-15. PubMed ID: 23534492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of the cutaneous penetration behavior of dexamethasone loaded to nano-sized lipid particles by EPR spectroscopy, and confocal Raman and laser scanning microscopy.
    Lohan SB; Saeidpour S; Solik A; Schanzer S; Richter H; Dong P; Darvin ME; Bodmeier R; Patzelt A; Zoubari G; Unbehauen M; Haag R; Lademann J; Teutloff C; Bittl R; Meinke MC
    Eur J Pharm Biopharm; 2017 Jul; 116():102-110. PubMed ID: 28043865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.
    Yang Y; Qiu D; Liu Y; Chao L
    Drug Des Devel Ther; 2019; 13():3307-3319. PubMed ID: 31571832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.